BRIEF — Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth STARLIGHT — 1 Trial Site

Oct 14 (Reuters) — Estrella Immunopharma Inc: Estrella Immunopharma Activates Intermountain Health Lds Hospital As Fifth Clinical Site For Phase I/ii Starlight-1 Trial In B-cell Non-hodgkin’s Lymphoma Source text:... Further company coverage: ESLA.O (reuters.briefs@thomsonreuters.com;)